Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
79.90
+0.60 (0.76%)
Jun 2, 2026, 12:55 PM EDT - Market open
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $5.99 billion as of June 2, 2026. Its market cap has increased by 152.45% in one year.
Market Cap
5.99B
Enterprise Value
4.70B
1-Year Change
152.45%
Ranking
Category
Stock Price
$79.90
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $5.99B, an increase of 640.32%. That is a compound annual growth rate of 100.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 5.94B | 16.67% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.45B |
| Centessa Pharmaceuticals | 6.17B |
| Spyre Therapeutics | 6.13B |
| PTC Therapeutics | 6.12B |
| Protagonist Therapeutics | 6.10B |
| Rhythm Pharmaceuticals | 6.02B |
| Celcuity | 6.00B |
| Cogent Biosciences | 5.95B |